TerezaMartinuMD

Pulmonology • Lumberton, NC

Critical Care Medicine

Assistant Professor, Medicine, Duke University School of Medicine

Join to view full profile

Are you Dr. Martinu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 43 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
300 W 27th St
Lumberton, NC 28358
Phone+1 910-671-5000

Fax+1 919-684-5266

Summary

Dr. Tereza Martinu, MD is a pulmonologist in Lumberton, North Carolina. She is currently licensed to practice medicine in North Carolina and Illinois. She is an Assistant Professor at Duke University School of Medicine.

Education & Training

Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008
Duke University HospitalResidency, Internal Medicine, 2002 - 2005
McGill University Faculty of MedicineClass of 2002

Certifications & Licensure

NC State Medical License 2005 - 2025
IL State Medical License 2019 - 2023

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

42 citations
Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantati...
Liran Levy, Ella Huszti, B. Renaud-Picard, Gregory Berra, M. Kawashima
The Journal of Heart and Lung Transplantation. 2020-08-01
515 citations
Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT
Geert Verleden, Allan R. Glanville, Erika D. Lease, Andrew J. Fisher, Fiorella Calabrese
The Journal of Heart and Lung Transplantation. 2019-04-03
58 citations
Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation.
D. Nakajima, Y. Watanabe, Akihiro Ohsumi, M. Pipkin, Manyin Chen
The Journal of Heart and Lung Transplantation. 2019-07-26

Press Mentions

IL‐6 Receptor Blockade for Allograft Dysfunction After Lung Transplantation in a Patient with COPA SyndromeJanuary 28th, 2021
ISHLT Elects New Board MembersJanuary 7th, 2021
Ontario Boy Almost Needed Double-Lung Transplant After Vaping: DoctorsNovember 21st, 2019
Join now to see all

Grant Support

Role Of CXC Chemokines At The Innate-Adaptive Interface Of Alloimmune Lung InjuryNational Heart, Lung, And Blood Institute2007